Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Whitehall Axid AR treatment claim places nizatidine on par with other H2s.

This article was originally published in The Tan Sheet

Executive Summary

AXID AR "RIGHT-BEFORE-EATING" LABEL DIRECTIONS FOR HEARTBURN PREVENTION were approved by FDA April 1. Labeling for the Whitehall-Robins nizatidine 75 mg stomach remedy product currently directs dosing at least 30 minutes before eating. The approval will make Axid AR the only H2 antagonist able to state in labeling it can be taken immediately before a meal to prevent heartburn.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088302

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel